Advertisement
FDA-designated breakthrough device offers first treatment option for severe TR and right HF
Also, earlier surgery likely benefits patients with severe functional TR
Q&A with writing committee member Miriam Jacob, MD
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement